Arachidonic and docosahexaenoic acids reduce the growth of A549 human lung-tumor cells increasing lipid peroxidation and PPARs

Chemico-Biological Interactions

Volumn 165, Issue 3, 2007, Pages 239-250

  Trombetta, Antonella ^a   Maggiora, Marina ^a   Martinasso, Germana ^a   Cotogni, Paolo ^a   Canuto, Rosa A ^a   Muzio, Giuliana ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

AP 1; Human lung cancer; Lipid peroxidation; PPARs; PUFAs

Indexed keywords

ALDEHYDE DERIVATIVE; ARACHIDONIC ACID; DOCOSAHEXAENOIC ACID; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; POLYUNSATURATED FATTY ACID;

ARTICLE; CANCER INHIBITION; CARCINOGENESIS; CELL PROLIFERATION; CELL STRAIN; CELL STRAIN A549; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA BINDING; DRUG EFFECT; GENE INDUCTION; GROWTH INHIBITION; HUMAN; HUMAN CELL; LIPID COMPOSITION; LIPID PEROXIDATION; LUNG TUMOR; MEMBRANE; TUMOR CELL; TUMOR GROWTH;

ADENOCARCINOMA; ANTINEOPLASTIC AGENTS; ARACHIDONIC ACID; CELL LINE, TUMOR; CELL PROLIFERATION; DOCOSAHEXAENOIC ACIDS; DOSE-RESPONSE RELATIONSHIP, DRUG; FATTY ACIDS; HUMANS; LIPID PEROXIDATION; LUNG NEOPLASMS; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS; TIME FACTORS; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION, GENETIC;

EID: 33846921554     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbi.2006.12.014     Document Type: Article

References (47)

1. Forman B.M., Chen J., and Evans R.M. Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 4312-4317
2. Kromhout D. The importance of N - 6 and N - 3 fatty acids in carcinogenesis. Med. Oncol. Tumor Pharmacother. 7 (1990) 173-176
3. Connolly J.M., Coleman M., and Rose D.P. Effects of dietary fatty acids on DU145 human prostate cancer cell growth in athymic nude mice. Nutr. Cancer 29 (1997) 114-119
4. Cesano A., Visonneau S., Scimeca J.A., Kritchevsky D., and Santoli D. Opposite effects of linoleic acid and conjugated linoleic acid on human prostatic cancer in SCID mice. Anticancer Res. 18 (1998) 1429-1434
5. Willett W.C. Diet and cancer. Oncologist 5 (2000) 393-404
6. Boyd N.F., Stone J., Vogt K.N., Connelly B.S., Martin L.J., and Minkin S. Dietary fat and breast cancer risk revisited: a meta-analysis of the published literature. Br. J. Cancer 89 (2003) 1672-1685
7. Calorini L., Fallani A., Tombaccini D., Mugnai G., and Ruggieri S. Lipid composition of cultured B16 melanoma cell variants with different lung-colonizing potential. Lipids 22 (1987) 651-656
8. Stubbs Jr. E.B., Carlson R.O., Lee C., Fisher S.K., Hajra A.K., and Agranoff B.W. Essential fatty acid deficiency in cultured SK-N-SH human neuroblastoma cells. Adv. Exp. Med. Biol. 318 (1992) 171-182
9. Murphy E.J., and Horrocks L.A. Composition of the phospholipids and their fatty acids in the ROC-1 oligodendroglial cell line. Lipids 28 (1993) 67-71
10. Canuto R.A., Ferro M., Muzio G., Bassi A.M., Leonarduzzi G., Maggiora M., Adamo D., Poli G., and Lindahl R. Role of aldehyde metabolizing enzymes in mediating effects of aldehyde products of lipid peroxidation in liver cells. Carcinogenesis 15 (1994) 1359-1364
11. Narayanan B.A., Narayanan N.K., and Reddy B.S. Docosahexaenoic acid (DHA) regulated genes and transcription factors inducing apoptosis in human colon cancer cells. Int. J. Oncol. 19 (2001) 1255-1262
12. Chamras H., Ardashian A., Heber D., and Glaspy J.A. Fatty acid modulation of MCF-7 human breast cancer cell proliferation, apoptosis and differentiation. J. Nutr. Biochem. 13 (2002) 711-716
13. Schonberg S.A., Rudra P.K., Noding R., Skorpen F., Bjerve K.S., and Krokan H.E. Evidence that changes in Se-glutathione peroxidase levels affect the sensitivity of human tumour cell lines to n - 3 fatty acids. Carcinogenesis 18 (1997) 1897-1904
14. Calviello G., Palozza P., Piccioni E., Maggiano N., Frattucci A., Franceschelli P., and Bartoli G.M. Dietary supplementation with eicosapentaenoic and docosahexaenoic acid inhibits growth of Morris hepatocarcinoma 3924A in rats: effects on proliferation and apoptosis. Int. J. Cancer 75 (1998) 699-705
15. Gonzalez B., Iturralde M., Alava M.A., Anel A., and Pineiro A. Metabolism of n - 9, n - 6 and n - 3 fatty acids in hepatoma Morris 7777 cells. Preferential accumulation of linoleic acid in cardiolipin. Prostaglandins Leukot. Essent. Fatty Acids 62 (2000) 299-306
16. Klieveri L., Fehres O., Griffini P., Van Noorden C.J., and Frederiks W.M. Promotion of colon cancer metastases in rat liver by fish oil diet is not due to reduced stroma formation. Clin. Exp. Metastasis 18 (2000) 1-7
17. Seeds M.C., and Bass D.A. Regulation and metabolism of arachidonic acid. Clin. Rev. Allergy Immunol. 17 (1999) 5-26
18. Razanamahefa L., Prouff S., and Bardon S. Stimulatory effect of arachidonic acid on T-47D human breast cancer cell growth is associated with enhancement of cyclin D1 mRNA expression. Nutr. Cancer 38 (2000) 274-280
19. Hughes-Fulford M., Chen Y., and Tjandrawinata R.R. Fatty acid regulates gene expression and growth of human prostate cancer PC-3 cells. Carcinogenesis 22 (2001) 701-707
20. Meterissian S., Kontogiannea M., Murty H., and Gupta A. Omega-6 fatty acids can inhibit Fas-mediated apoptosis in a human colorectal carcinoma cell line: a potential mechanism for escape from immune surveillance. Int. J. Surg. Invest. 2 (2000) 253-257
21. Begin M.E., Ells G., Das U.N., and Horrobin D.F. Differential killing of human carcinoma cells supplemented with n - 3 and n - 6 polyunsaturated fatty acids. J. Natl. Cancer Inst. 77 (1986) 1053-1062
22. Wu D., and Cederbaum A.I. Sodium salicylate increases CYP2E1 levels and enhances arachidonic acid toxicity in HepG2 cells and cultured rat hepatocytes. Mol. Pharmacol. 59 (2001) 795-805
23. Muzio G., Salvo R.A., Trombetta A., Autelli R., Maggiora M., Terreno M., Dianzani M.U., and Canuto R.A. Dose-dependent inhibition of cell proliferation induced by lipid peroxidation products in rat hepatoma cells after enrichment with arachidonic acid. Lipids 34 (1999) 705-711
24. Sravan Kumar G., and Das U.N. Cytotoxic action of alpha-linolenic and eicosapentaenoic acids on myeloma cells in vitro. Prostaglandins Leukot. Essent. Fatty Acids 56 (1997) 285-293
25. Schonberg S.A., and Skorpen F. Paracetamol counteracts docosahexaenoic acid-induced growth inhibition of A-427 lung carcinoma cells and enhances tumor cell proliferation in vitro. Anticancer Res. 17 (1997) 2443-2448
26. Maehle L., Lystad E., Eilertsen E., Einarsdottir E., Hostmark A.T., and Haugen A. Growth of human lung adenocarcinoma in nude mice is influenced by various types of dietary fat and vitamin E. Anticancer Res. 19 (1999) 1649-1655
27. Kudryavtsev I.A., Golenko O.D., Gudkova M.V., and Myasishcheva N.V. Arachidonic acid metabolism in growth control of A549 human lung adenocarcinoma cells. Biochemistry 67 (2002) 1021-1026
28. Barbiero G., Duranti F., Bonelli G., Amenta J.S., and Baccino F.M. Intracellular ionic variations in the apoptotic death of L cells by inhibitors of cell cycle progression. Exp. Cell Res. 217 (1995) 410-418
29. Kornberg A. Lactic dehydrogenase of muscle. In: Colowick S.P., and Kaplan N.D. (Eds). Methods of Enzymology vol. 1 (1955), Academic Press, New York 441-443
30. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 (1970) 680-685
31. Canuto R.A., Muzio G., Bassi A.M., Maggiora M., Leonarduzzi G., Lindahl R., Dianzani M.U., and Ferro M. Enrichment with arachidonic acid increases the sensitivity of hepatoma cells to the cytotoxic effects of oxidative stress. Free Radic. Biol. Med. 18 (1995) 287-293
32. Folch J., Lees M., and Sloane Stanley G.H. A simple method for the isolation and purification of total lipides from animal tissues. J. Biol. Chem. 226 (1957) 497-509
33. Metcalfe L.D., Pelka J.R., and Schmitz A.A. Rapid preparation of fatty acid esters for gas-chromatographic analysis. Anal. Chem. 38 (1966) 514-515
34. Arkan M.C., Leonarduzzi G., Biasi F., Basaga H., and Poli G. Physiological amounts of ascorbate potentiate phorbol ester-induced nuclear-binding of AP-1 transcription factor in cells of macrophagic lineage. Free Radic. Biol. Med. 31 (2001) 374-382
35. Vento R., D'Alessandro N., Giuliano M., Lauricella M., Carabillo M., and Tesoriere G. Induction of apoptosis by arachidonic acid in human retinoblastoma Y79 cells: involvement of oxidative stress. Exp. Eye Res. 70 (2000) 503-517
36. Desvergne B., Michalik L., and Wahli W. Be fit or be sick: peroxisome proliferator-activated receptors are down the road. Mol. Endocrinol. 18 (2004) 1321-1332
37. Michalik L., Desvergne B., and Wahli W. Peroxisome-proliferator-activated receptors and cancers: complex stories. Nat. Res. Cancer 4 (2004) 61-70
38. Na H.K., and Surh Y.J. Peroxisome proliferator-activated receptor gamma (PPARgamma) ligands as bifunctional regulators of cell proliferation. Biochem. Pharmacol. 66 (2003) 1381-1391
39. Di-Poi N., Michalik L., Tan N.S., Desvergne B., and Wahli W. The anti-apoptotic role of PPARbeta contributes to efficient skin wound healing. J. Steroid Biochem. Mol. Biol. 85 (2003) 257-265
40. Awasthi Y.C., Sharma R., Cheng J.Z., Yang Y., Sharma A., Singhal S.S., and Awasthi S. Role of 4-hydroxynonenal in stress-mediated apoptosis signaling. Mol. Aspects Med. 24 (2003) 219-230
41. Forman J., Dickinson D.A., and Iles K.E. HNE-signaling pathways leading to its elimination. Mol. Aspects Med. 24 (2003) 189-194
42. Biswal S., Acquaah-Mensah G., Datta K., Wu X., and Kehrer J.P. Inhibition of cell proliferation and AP-1 activity by acrolein in human A549 lung adenocarcinoma cells due to thiol imbalance and covalent modifications. Chem. Res Toxicol. 15 (2002) 180-186
43. Liu G., Bibus D.M., Bode A.M., Ma W.Y., Holman R.T., and Dong Z. Omega 3 but not omega 6 fatty acids inhibit AP-1 activity and cell transformation in JB6 cells. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 7510-7515
44. Pizzimenti S., Laurora S., Briatore F., Ferretti C., Dianzani M.U., and Barrera G. Synergistic effect of 4-hydroxynonenal and PPAR ligands in controlling human leukemic cell growth and differentiation. Free Radic. Biol. Med. 32 (2002) 233-245
45. Calder P.C. Polyunsaturated fatty acids and inflammation. Biochem. Soc. Trans. 33 (2005) 423-427
46. Fan X.M., Tu S.P., Lam S.K., Wang W.P., Wu J., Wong W.M., Yuen M.F., Lin M.C., Kung H.F., and Wong B.C. Five-lipoxygenase-activating protein inhibitor MK-886 induces apoptosis in gastric cancer through upregulation of p27kip1 and bax. J. Gastroenterol. Hepatol. 19 (2004) 31-37
47. Hoferova Z., Soucek K., Hofmarova J., Hofer M., Chramostova K., Fedorocko P., and Kozubik A. In vitro proliferation of fibrosarcoma cells depends on intact functions of lipoxygenases and cytochrome P-450-monooxygenase. Cancer Invest. 22 (2004) 234-247